Cygnus Biosciences
Latest round
- Series C
Last raised
- Mar 2023
Total raised
- $49M
Investors
- 18
About Cygnus Biosciences
Established in 2015 and based in Beijing, China,Cygnus Biosciences is a biotechnology company which focuses on the R&D in DNA sequencing platforms, screening and diagnosis of clinical medicine. The company was founded by the team of academician Xiaoliang Xie, Yanyi Huang and Zitian Chen from Peking University. In 2016, the firm completed the design and development of the prototype of the sequencer. In 2018, it established a wholly-owned subsidiary Dyna Technology. Its first S100 gene sequencer was officially launched in 2022. In June 2022, the company's S100 gene sequencer and its accompanying sequencing kit was awarded CE-IVDR certification by the European Union. Cygnus Biosciences also has chemical and enzyme raw material production base, GMP reagent production workshop and instrument production factory. The company has two core sequencing technologies, fluorogenic and error correction coding (ECC). Its products can be categorized into three categories which are sequencers and sequencing reagents. Products within include S100 sequencer and universal kit for sequencing reactions. The company's products are used in the fields of pathogenic microorganisms, oncology, reproductive health, genetic diseases, agricultural breeding and other fields. The company generates revenue through the sale of sequencing instruments and reagents used in medical diagnostics, scientific research and agricultural applications.
Who invested in Cygnus Biosciences
18 investors across 5 rounds
See all investors in Cygnus Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cygnus Biosciences
Who invested in Cygnus Biosciences?
Cygnus Biosciences has 18 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cygnus Biosciences raised?
Cygnus Biosciences has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Cygnus Biosciences last raise money?
Cygnus Biosciences's most recent round on record is a Series C, in Mar 2023.
What does Cygnus Biosciences do?
Established in 2015 and based in Beijing, China,Cygnus Biosciences is a biotechnology company which focuses on the R&D in DNA sequencing platforms, screening and diagnosis of clinical medicine.
Where is Cygnus Biosciences headquartered?
Cygnus Biosciences is headquartered in Beijing, China.
Which VCs invest in companies like Cygnus Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Cygnus Biosciences's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Cygnus Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.